ATYR aTyr Pharma
- 1.890
- +0.010+0.53%
- 1.870
- -0.020-1.06%
aTyr Pharma News
aTyr Pharma | 4: Statement of changes in beneficial ownership of securities-Director SCHIMMEL PAUL
4: Statement of changes in beneficial ownership of securities-Officer DENYES NANCY
aTyr Pharma | 4: Statement of changes in beneficial ownership of securities-Director COUGHLIN TIMOTHY
aTyr Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Broadfoot Jill Marie
aTyr Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Shukla Sanjay
aTyr Pharma | 4: Statement of changes in beneficial ownership of securities-Director CLARKE JOHN K
aTyr Pharma | 4: Statement of changes in beneficial ownership of securities-Director Gross Jane A
aTyr Pharma | 4: Statement of changes in beneficial ownership of securities-Director Lucas Svetlana
aTyr Pharma | 4: Statement of changes in beneficial ownership of securities-Director SCHIMMEL PAUL
aTyr Pharma | 4: Statement of changes in beneficial ownership of securities-Director Zaknoen Sara
aTyr Pharma | 4: Statement of changes in beneficial ownership of securities-Director COUGHLIN TIMOTHY
aTyr Pharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Laurence W. Lytton(1.0%)
aTyr Pharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)
aTyr Pharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(14.999%),Abigail P. Johnson(14.999%)
aTyr Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Shukla Sanjay
aTyr Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Broadfoot Jill Marie
aTyr Pharma | 4: Statement of changes in beneficial ownership of securities-Officer DENYES NANCY
aTyr Pharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Federated Hermes, Inc.(17.37%),Voting Shares Irrevocable Trust(17.37%), etc.
aTyr Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Shukla Sanjay
aTyr Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Broadfoot Jill Marie
Analysis
Price Target
No Data
